SKI Market

A+| A| A-|

Indian Indices

Sensex

77,502.12 579.48
( 0.75%)

Global Indices

Nasdaq

52,333.78 -6.42
(-0.01%)

Dow Jones

7,505.37 -14.99
(-0.20%)

Hang Seng

68,854.54 -1,620.42
(-2.30%)

Nikkei 225

10,484.10 -13.02
(-0.12%)

Forex

USD-INR

94.60 0.11
(0.12%)

EUR-INR

107.91 0.13
(0.12%)

GBP-INR

125.27 0.26
(0.21%)

JPY-INR

0.58 0.00
(-0.20%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Globe Commercials Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

540266

INE804Q01013

36.784905

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

1.3

11.28

EPS(TTM)

Face Value()

Div & Yield %

14.5

Back

Oxygenta Pharmaceutical reports standalone net loss of Rs 4.84 crore in the December 2025 quarter

Feb 05,2026

Net Loss of Oxygenta Pharmaceutical reported to Rs 4.84 crore in the quarter ended December 2025 as against net loss of Rs 3.93 crore during the previous quarter ended December 2024. Sales rose 2.17% to Rs 33.93 crore in the quarter ended December 2025 as against Rs 33.21 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	33.93	33.21	2
OPM %	-12.00	-13.10	-
PBDT	-5.46	-4.25	-28
PBT	-6.32	-4.96	-27
NP	-4.84	-3.93	-23

77,502.12 579.48 ( 0.75%)

52,333.78 -6.42 (-0.01%)

7,505.37 -14.99 (-0.20%)

68,854.54 -1,620.42 (-2.30%)

10,484.10 -13.02 (-0.12%)

94.60 0.11 (0.12%)

107.91 0.13 (0.12%)

125.27 0.26 (0.21%)

0.58 0.00 (-0.20%)